ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,741Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 1454

$911K Total Retail Price of All Prescriptions

Rank: 119 out of 1454

534 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,200 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LOVASTATIN 831 591 1 39
OMEPRAZOLE 777 545 2 3
LISINOPRIL 724 569 3 4
FUROSEMIDE 671 491 4 6
HYDROCODONE-ACETAMINOPHEN 625 404 S3 5 7
CRESTOR 621 432 6 22
METOPROLOL TARTRATE 610 476 7 10
LEVOTHYROXINE SODIUM 574 487 8 5
SIMVASTATIN 542 381 9 1
AMLODIPINE BESYLATE 388 327 10 2
POTASSIUM CHLORIDE 376 297 11 15
METFORMIN HCL 343 177 12 8
FENOFIBRATE 320 194 13 68
GLIMEPIRIDE 311 210 14 33
ATORVASTATIN CALCIUM 246 152 15 11
CIPROFLOXACIN HCL 240 171 16 64
WARFARIN SODIUM 216 169 17 17
GABAPENTIN 215 135 18 16
NEXIUM 212 133 19 23
METOPROLOL SUCCINATE 205 150 20 13
ISOSORBIDE MONONITRATE ER 193 163 21 46
ATENOLOL 181 142 22 18
PROMETHAZINE HCL 172 95 R 23 82
CLOPIDOGREL 168 133 24 32
ZOLPIDEM TARTRATE 162 73 25 19
TRAMADOL HCL 161 90 26 20
HYDROCHLOROTHIAZIDE 155 112 27 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 155 104 27 27
LOSARTAN POTASSIUM 150 108 29 14
RANITIDINE HCL 150 100 29 43
LEVOXYL 142 114 31 84
CARVEDILOL 139 97 32 24
TRAZODONE HCL 137 95 33 50
TRIAMTERENE-HCTZ 130 95 34 44
PLAVIX 130 102 34 45
JANUVIA 130 66 34 77
DONEPEZIL HCL 127 115 37 29
MELOXICAM 122 107 38 37
CITALOPRAM HBR 118 100 39 21
TRICOR 116 60 40 134
CYCLOBENZAPRINE HCL 102 44 R 41 59
ALLOPURINOL 100 88 42 28
SERTRALINE HCL 97 56 43 26
SUCRALFATE 96 69 44 227
CEPHALEXIN 93 71 45 127
BENAZEPRIL HCL 91 76 46 57
RAMIPRIL 91 76 46 66
PROAIR HFA 89 63 48 56
ALENDRONATE SODIUM 88 82 49 35
TAMSULOSIN HCL 87 71 50 34
ADVAIR DISKUS 86 53 51 47
POLYETHYLENE GLYCOL 3350 86 83 51 61
LIPITOR 85 65 53 74
AMITRIPTYLINE HCL 85 62 R 53 71
DIOVAN 83 61 55 40
NAMENDA 79 67 56 48
BUSPIRONE HCL 78 65 57 176
AMLODIPINE BESYLATE-BENAZEPRIL 74 70 58 65
HYDROXYZINE HCL 70 57 R 59 183
FENTANYL 68 51 S2 60 104
VERAPAMIL ER 68 28 60 89
NABUMETONE 67 53 62 204
LANTUS 65 15 63 51
LEVEMIR FLEXPEN 65 19 63 171
SYNTHROID 63 61 65 25
BYSTOLIC 62 37 66 110
KLOR-CON M20 62 56 66 54
HYDRALAZINE HCL 59 46 68 67
FOSINOPRIL SODIUM 58 58 69 249
PROPRANOLOL HCL 58 58 69 129
CYMBALTA 57 30 71 55
CLONIDINE HCL 56 36 72 49
LOSARTAN-HYDROCHLOROTHIAZIDE 56 25 72 38
EVISTA 56 44 72 136
DILTIAZEM 24HR CD 55 45 75 76
TRIAMCINOLONE ACETONIDE 54 46 76 142
BACLOFEN 53 26 77 146
NOVOLOG MIX 70-30 FLEXPEN 53 17 77 211
AZITHROMYCIN 51 34 79 42
PRAMIPEXOLE DIHYDROCHLORIDE 51 45 79 200
MIRTAZAPINE 50 37 81 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.